Braunschweig, July 19, 2023 – YUMAB announces its collaboration with InSCREENeX under the “exPDITE” funding project. The goal of the collaboration is to enable improved drug development for the individual treatment of patients with pancreatic cancer. To this end, patient-specific tissues will be propagated in the laboratory using InSCREENeX’s CI-SCREEN technology to identify new tumor targets using YUMAB’s proprietary antibody databases.
Contact
YUMAB GmbH
Alexander Ehm
Phone: +49-170-2800357
Email: info@yumab.com
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17
